Unblocking of NMDA receptors, glutamate binding and activation
REACTOME PATHWAYThe Unblocking of NMDA receptors, glutamate binding and activation pathway (Reactome ID: R-HSA-438066) involves 10 genes and is affected by 30 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting Unblocking of NMDA receptors, glutamate binding and activation
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | Glutamic Acid | — | 297 |
| 2 | Glutamic Acid | — | 300 |
| 3 | Glycine | — | 300 |
| 4 | pentamidine | — | 299 |
| 5 | Dextromethorphan Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of | — | 296 |
| 6 | Dextrorphan Dextro form of levorphanol. It acts as | — | 300 |
| 7 | Levorphanol | — | 297 |
| 8 | cycloserine | — | 298 |
| 9 | Aspartic Acid | — | 300 |
| 10 | D-Aspartic Acid | — | 29 |
| 11 | Ethidium | — | 300 |
| 12 | Dextrothyroxine | — | 134 |
| 13 | Dizocilpine Maleate | — | 300 |
| 14 | Ibotenic Acid | — | 300 |
| 15 | Spermine | — | 300 |
| 16 | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | — | 300 |
| 17 | aniracetam | — | 110 |
| 18 | Piracetam | — | 300 |
| 19 | eliprodil | — | 33 |
| 20 | Memantine AMANTADINE derivative that has some dopaminergic effects. It has been proposed as | — | 34 |
| 21 | KN 92 [Supplementary Concept] KN 93 isomer; | — | 26 |
| 22 | sp600125 | — | 117 |
| 23 | Kynurenic Acid | — | 300 |
| 24 | Phenformin | — | 300 |
| 25 | Carvedilol | — | 296 |
| 26 | Ibogaine | — | 300 |
| 27 | Riluzole | — | 298 |
| 28 | Quercetin | — | 300 |
| 29 | Sorafenib | — | 300 |
| 30 | alsterpaullone | — | 12 |
About the Unblocking of NMDA receptors, glutamate binding and activation Pathway
The Unblocking of NMDA receptors, glutamate binding and activation pathway is catalogued in Reactome (ID: R-HSA-438066) and involves 10 genes. In the BiohacksAI corpus, 30 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CAMK2B, CAMK2D, GRIA1, GRIA2, GRIA3.